Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakub Hort

Showing results (61-70 of 185) with videos related to

Pageof 19
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsMonika Krejci, Veronika Matuskova, Toni T Saari, et al.
Journal of Alzheimer'S Disease : JAD|December 15, 2025
Comparing self and informant perspectives on neuropsychiatric symptoms in older adults in a memory clinicMonika Krejčí, Veronika Matušková, Toni T Saari, et al.
Journal of Alzheimer'S Disease : JAD|July 13, 2017
Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive SymptomsHana Markova, Ross Andel, Hana Stepankova, et al.
BMC Neurology|May 17, 2011
FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three casesRobert Rusina, Gabor G Kovacs, Jindřich Fiala, et al.
Current Medical Research and Opinion|November 9, 2007
Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapyParaskevi Sakka, Magda Tsolaki, Jakub Hort, et al.
ACS Omega|June 23, 2025
Dementia with Lewy Bodies (DLB), Parkinson's Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1)Francesco Angelucci, Zuzana Nedelska, Blanka Napravnikova Manová, et al.
Plos One|July 7, 2018
Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndromeEva Hyncicova, Adam Kalina, Martin Vyhnalek, et al.
Scientific Reports|January 22, 2026
Spatial pattern separation deficits in early Alzheimer's disease are comparable in humans and animal modelsMartina Laczó, Kristyna Maleninska, Natalie Khazaalova, et al.
CNS Drugs|August 5, 2018
Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human BrainJohn A Hey, Petr Kocis, Jakub Hort, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Spatial navigation impairment is proportional to right hippocampal volumeZuzana Nedelska, Ross Andel, Jan Laczó, et al.
Pageof 19

Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsMonika Krejci, Veronika Matuskova, Toni T Saari, et al.
Journal of Alzheimer'S Disease : JAD|December 15, 2025
Comparing self and informant perspectives on neuropsychiatric symptoms in older adults in a memory clinicMonika Krejčí, Veronika Matušková, Toni T Saari, et al.
Journal of Alzheimer'S Disease : JAD|July 13, 2017
Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive SymptomsHana Markova, Ross Andel, Hana Stepankova, et al.
BMC Neurology|May 17, 2011
FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three casesRobert Rusina, Gabor G Kovacs, Jindřich Fiala, et al.
Current Medical Research and Opinion|November 9, 2007
Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapyParaskevi Sakka, Magda Tsolaki, Jakub Hort, et al.
ACS Omega|June 23, 2025
Dementia with Lewy Bodies (DLB), Parkinson's Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1)Francesco Angelucci, Zuzana Nedelska, Blanka Napravnikova Manová, et al.
Plos One|July 7, 2018
Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndromeEva Hyncicova, Adam Kalina, Martin Vyhnalek, et al.
Scientific Reports|January 22, 2026
Spatial pattern separation deficits in early Alzheimer's disease are comparable in humans and animal modelsMartina Laczó, Kristyna Maleninska, Natalie Khazaalova, et al.
CNS Drugs|August 5, 2018
Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human BrainJohn A Hey, Petr Kocis, Jakub Hort, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Spatial navigation impairment is proportional to right hippocampal volumeZuzana Nedelska, Ross Andel, Jan Laczó, et al.
Pageof 19